Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclin T2 pseudogene 1 (CCNT2P1) refers to a pseudogene related to the functional gene Cyclin T2 (CCNT2). Pseudogenes are nonfunctional copies or segments of genes that do not produce functional protein products. CCNT2P1 is not a protein-coding gene, nor is it known to have biological activity, therapeutic relevance, or direct disease involvement. The functional Cyclin T2 gene (CCNT2) encodes a regulatory subunit of the CDK9/cyclin T complex, important in transcriptional elongation, cell cycle, and development, but pseudogenes like CCNT2P1 lack this protein function[1][2][3][6]. Context and interpretation: "CCNT2P1" is not a canonical therapeutic target but a pseudogene related to Cyclin T2. Pseudogenes are not used as drug targets and have no known disease associations or molecular functions. All structured biological and pharmacological information (e.g., drug interactions, mechanisms, biomarkers) is inapplicable to CCNT2P1. If the intent is to inquire about the functional protein Cyclin T2 (CCNT2), information should be gathered for "Cyclin T2" instead, which is a true protein-coding gene with established molecular and biological roles[1][2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin T2 pseudogene 1 (CCNT2P1).